Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
Authors
Keywords
-
Journal
EBioMedicine
Volume 82, Issue -, Pages 104141
Publisher
Elsevier BV
Online
2022-07-27
DOI
10.1016/j.ebiom.2022.104141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
- (2022) David W. Eyre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- (2022) Juliet R. C. Pulliam et al. SCIENCE
- Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
- (2022) Kanika Bansal et al. VIRUS RESEARCH
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
- (2021) Darren P. Martin et al. CELL
- Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State
- (2021) Abbye E McEwen et al. CLINICAL INFECTIOUS DISEASES
- The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity
- (2021) Simon D Pollett et al. CLINICAL INFECTIOUS DISEASES
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
- (2021) Talia Kustin et al. NATURE MEDICINE
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
- (2021) Ross J. Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
- (2021) Jocelyn Keehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021
- (2021) Tracy Lam-Hine et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
- (2021) Eli S. Rosenberg et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
- (2021) Ashley Fowlkes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
- (2021) Po Ying Chia et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
- (2021) Carolina Lucas et al. NATURE
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
- (2021) Akatsuki Saito et al. NATURE
- Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
- (2021) Keiya Uriu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant
- (2021) Fabian Schmidt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
- (2021) Jun Zhang et al. SCIENCE
- Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland
- (2021) Chaoran Chen et al. Epidemics
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
- (2020) Hongjing Gu et al. SCIENCE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nextstrain: real-time tracking of pathogen evolution
- (2018) James Hadfield et al. BIOINFORMATICS
- FUBAR: A Fast, Unconstrained Bayesian AppRoximation for Inferring Selection
- (2013) B. Murrell et al. MOLECULAR BIOLOGY AND EVOLUTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search